|
Post Event
ISCR hosted 3rd annual conference in Bengaluru
Our News Bureau - Mumbai
The third annual conference of Indian Society for Clinical Research (ISCR)
in Bengaluru, themed 'Science, Business and Society also saw the launch of its
first journal for the clinical research industry titled 'Perspectives in Clinical
Research' comprising insights of the best minds in the space with new views
on the clinical research landscape. The journal is available in print and online
at www.iscr.org/journal.
In the clinical research seminar track, regulatory issues were addressed by
Dr Suresh Menon, Novartis India, Dr Bobby George, Reliance Life Sciences India,
Dr Radhika Bobba, Anhvita Biopharm Consulting, Sumati Randeo, Abott Vascular
India with the legal angle by Thiruvengadam, Thiru and Thiru India. The conference
also featured ethical challenges with vulnerable populations from stakeholders
like Dr Radhika Bobba, Dr Manish Shah, Pfizer India, Dr Nagasubbramaniam, Manipal
Health and Dr Mohandas, Tata Memorial Center, moderated by Dr Urmila Thate,
KEM Hospital. The track concluded with research methodology discussions on end
points in oncology trials, design of Phase I studies and NIS studies by Dr Anurita
Majumdar, Eli Lilly India, Dr Viraj Suvarna and Dr Rajyadhaksha, Pfizer India,
Dr Usharani, Nizam's Institute of Medical Science and Dr Mohandas.
The CDM, medical writing and biostatistics tracks had discussions by Dr Suresh
Bowalekar, Pharmanet clinical services, Dr Steve Wilson, FDA USA, Anilkumar
, Novartis, Kalyan Gopalkrishnan and Ilango Ramanujam, TAKE Solutions. Other
challenging areas of CDM were covered by Dr Laxminarayan, Merck Research Laboratories,
Dr Bhattacharya, GlaxoSmithkline Pharma, Dr Mary Johnson, Pharmanet Development
Group, Dr Ram Tiwari, FDA and Dr Tandon, Genzyme Corporate Inc. The day concluded
with a track on quality and data integration by Dr Tandon, Dr Nema of TCS, Dr
Handleman, SAS Institute Inc, Dr Sunil Singh and Dr Salil Varma, DBMS Consulting
Inc.
|